ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/-
AC   CVCL_D1ID
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; H9 FAM134A/B/C/TEX264-/-
DR   Wikidata; Q127381003
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; 13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IC ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=38429475; DOI=10.1038/s41556-024-01356-4; PMCID=PMC10940164;
RA   Hoyer M.J., Capitanio C., Smith I.R., Paoli J.C., Bieber A.,
RA   Jiang Y.-Z., Paulo J.A., Gonzalez-Lozano M.A., Baumeister W.P.,
RA   Wilfling F., Schulman B.A., Harper J.W.;
RT   "Combinatorial selective ER-phagy remodels the ER during
RT   neurogenesis.";
RL   Nat. Cell Biol. 26:378-392(2024).
//